Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits

Nature Neuroscience

Volumn 13, Issue 8, 2010, Pages 920-922

  Tost, Heike ^a,b   Braus, Dieter F ^a,c   Hakimi, Shabnam ^b   Ruf, Matthias ^a   Vollmert, Christian ^a   Hohn, Fabian ^a   Meyer Lindenberg, Andreas ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c DR HORST SCHMIDT KLINIKEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; HALOPERIDOL; DOPAMINE RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BRAIN CORTEX; GENE EXPRESSION; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; MOTOR ACTIVITY; MOTOR CONTROL; NERVE CELL PLASTICITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; CORPUS STRIATUM; DRUG ANTAGONISM; DRUG EFFECT; NERVE TRACT;

ADULT; ANTIPSYCHOTIC AGENTS; CEREBRAL CORTEX; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; HALOPERIDOL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEURAL PATHWAYS; NEURONAL PLASTICITY; RECEPTORS, DOPAMINE D2; YOUNG ADULT;

EID: 77955054491     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn.2572     Document Type: Article

References (15)

1. Kamin, J., Manwani, S. & Hughes, D. Psychiatr. Serv. 51, 287-289 (2000).
2. Wong, D.F., Grunder, G. & Brasic, J.R. Int. Rev. Psychiatry 19, 541-558 (2007).
3. Kovács, K.J., Csejtei, M. & Laszlovszky, I. Neuropharmacology 40, 383-393 (2001).
4. Chartoff, E.H., Ward, R.P. & Dorsa, D.M. J. Pharmacol. Exp. Ther. 291, 531-537 (1999).
5. Miyashita, T., Kubik, S., Lewandowski, G. & Guzowski, J.F. Neurobiol. Learn. Mem. 89, 269-284 (2008).
6. Tost, H. et al. Biol. Psychiatry 60, 1196-1205 (2006).
7. Meyer-Lindenberg, A. et al. J. Clin. Invest. 117, 672-682 (2007).
8. Alexander, G.E., Crutcher, M.D. & DeLong, M.R. Prog. Brain Res. 85, 119-146 (1990).
9. Parish, C.L. et al. Eur. J. Neurosci. 16, 787-794 (2002).
10. Parish, C.L., Finkelstein, D.I., Drago, J., Borrelli, E. & Horne, M.K. J. Neurosci. 21, 5147-5157 (2001).
11. Samaha, A.N. et al. Biol. Psychiatry 64, 145-152 (2008).
12. Marchese, G. et al. Eur. J. Neurosci. 15, 1187-1196 (2002).
13. Driemeyer, J., Boyke, J., Gaser, C., Buchel, C. & May, A. PLoS One 3, e2669 (2008).
14. Xu, M.Q. et al. Pharmacogenet. Genomics 18, 449-457 (2008).
15. Dawson, N.M., Hamid, E.H., Egan, M.F. & Meredith, G.E. Synapse 39, 70-81 (2001).